Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Adherium Ltd. ( (AU:ADR) ) is now available.
Adherium Ltd., a Melbourne-based provider of digital respiratory health solutions, has repositioned its corporate footprint within the city’s central business district. The company’s registered office has moved to Collins Place on Collins Street, while its principal place of business has shifted to a separate Collins Street location, consolidating operations in a key commercial precinct.
The relocation of both its registered office and main operating base may streamline Adherium’s corporate administration and support functions, potentially enhancing accessibility for investors and partners. While the announcement is administrative in nature, it underscores the company’s continued establishment in Melbourne as it advances its connected respiratory device and data platform offerings.
The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.
More about Adherium Ltd.
Adherium Ltd. is a digital health company specialising in connected respiratory medical devices and integrated monitoring solutions. Its Hailie platform enables clinicians, healthcare providers and patients to remotely track respiratory medication use and adherence, integrating data via mobile and desktop apps, SDKs, APIs and proprietary sensor-equipped inhaler devices.
Technical Sentiment Signal: Sell
Current Market Cap: A$12.36M
For a thorough assessment of ADR stock, go to TipRanks’ Stock Analysis page.